SCHEMBL10167501

SCHEMBL10167501

CCC(=O)N(C)c1nsc2cccc(OC)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.40
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
RAD52 P43351 2/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 3/20 0.36
HSD17B10 Q99714 3/20 0.36
BACE1 P56817 1/20 0.36
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
HPGD P15428 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TRPC6 Q9Y210 1/20 0.35
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167507 0.90 KDM4E (0.40) KCNA5MEN1KMT2ARAD52ALDH1A1
SCHEMBL10167513 0.86 KCNA5 (0.42) KCNA5MEN1KMT2ARAD52ALDH1A1
SCHEMBL10167484 0.85 HCRTR1 (0.35) MEN1KMT2AALDH1A1KDM4EHSD17B10
SCHEMBL10167444 0.85 KCNA5 (0.40) KCNA5ALDH1A1BACE1RAB9ANPC1
SCHEMBL352608 0.83 GAA (0.35) MEN1KMT2ARAD52KDM4ERAB9A
SCHEMBL10167512 0.82 MAPT (0.39) KCNA5ALDH1A1KDM4EHSD17B10BACE1
SCHEMBL10167447 0.82 ALDH1A1 (0.40) KMT2AALDH1A1KDM4EHPGDUSP2
SCHEMBL10167504 0.81 KCNA5 (0.45) KCNA5MEN1KMT2ARAD52KDM4E
SCHEMBL13903768 0.80 KCNA5 (0.44) KCNA5MEN1KMT2ARAD52ALDH1A1
SCHEMBL292530 0.80 KCNA5 (0.40) KCNA5MEN1KMT2ARAD52BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
WO-2008090048-A2 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BPNT1, BCAT1, TGFBR1 KCNA5 1882/4885MEN1 3020/4885KMT2A 2749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.